Soleno Therapeutics, Inc.SLNONASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank77
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
12.58
↑ 133% vs avg
Percentile
P77
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
5.39
Historical baseline
PeriodValueYoY Change
202512.58-
20240.00-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-
20180.00+100.0%
2017-0.04-100.1%
201641.41-